William M. Grady, MD, of Fred Hutchinson Cancer Center, continues his break down of the colorectal cancer screening landscape, offering his thoughts on whether colonoscopy, stool-based tests, or blood-based tests will be integrated into screening guidelines (or given on a patient-by-patient basis).
Dr. Grady concludes with a note on the continued direction of the ECLIPSE study for the Shield test.
View his previous comments on Colorectal Cancer Screening: Shield and the ECLIPSE Study.